Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 May 26;18(12):2873–2884. doi: 10.1111/ajt.14874

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 The Authors. American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Reduction of CD45⁺ cells in inflamed corneas after coneal crosslinking (CXL). A‐F. Representative images of CD45⁺ cells in corneas excised 4 days or 8 days after CXL (magnification: ×400; scale bar: 50 μm). G. CD45⁺ cells in inflamed corneas decreased by 61.7% in 6‐minutes CXL–treated group and 69.2% in 9‐minutes CXL–treated group with a significant difference at 4 days post CXL compared with the control group. At 8 days after CXL, CD45⁺ cells in corneas also decreased significantly (6‐minutes CXL: 28.5%; 9‐minutes CXL: 46.6%) compared with the control group (n = 5; *P < .05, **^* P < .001, *^*** P < .0001)